New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

Heldrup J, Bleyer A, Ramsey L, Schaff L, Bernhardt B, Schwartz S, Chatelut E, Hwang M, Ten C, Guscott M, Howard S.

Open source

DOI
10.1007/s00280-025-04749-w
Published
2025-03-13
Container
Cancer Chemother Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-025-04749-w,
  title = {New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.},
  author = {Heldrup J and  Bleyer A and  Ramsey L and  Schaff L and  Bernhardt B and  Schwartz S and  Chatelut E and  Hwang M and  Ten C and  Guscott M and  Howard S.},
  year = {2025},
  journal = {Cancer Chemother Pharmacol},
  doi = {10.1007/s00280-025-04749-w},
  url = {https://doi.org/10.1007/s00280-025-04749-w}
}

RIS

TY  - JOUR
TI  - New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.
AU  - Heldrup J
AU  -  Bleyer A
AU  -  Ramsey L
AU  -  Schaff L
AU  -  Bernhardt B
AU  -  Schwartz S
AU  -  Chatelut E
AU  -  Hwang M
AU  -  Ten C
AU  -  Guscott M
AU  -  Howard S.
PY  - 2025
JO  - Cancer Chemother Pharmacol
DO  - 10.1007/s00280-025-04749-w
UR  - https://doi.org/10.1007/s00280-025-04749-w
ER  - 

APA

J, H., A, B., L, R., L, S., B, B., S, S., E, C., M, H., C, T., M, G., & S., H. (2025). New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-025-04749-w

Source records